Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-100 Re-treatment in Knee Osteoarthritis
NCT02837900Phase 2Completed
- Sponsor
- OrthoTrophix, Inc.
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of TPX-100 in osteoarthritis (OA), sponsored by OrthoTrophix, Inc.. Started Aug 2016; status: completed.
02
Drugs
TPX-100
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02837900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837900.